Important: New Requirements for Applying to the HHS SBIR Omnibus Solicitation

NCI Cancer Grant Funding

HHS Re-issues 2013 Omnibus Solicitation to Implement Additional Provisions of the SBIR/STTR

Reauthorization Act of 2011
Original 2013 SBIR/STTR Omnibus Solicitations are now expired

All applicants to the National Cancer Institute (NCI) SBIR & STTR Programs must use the re-issued PHS 2013-2 Omnibus Grant Solicitations, PA-13-234 (SBIR) and PA-13-235 (STTR) for the upcoming August 5 and December 5 deadlines.

Funding is available to support small businesses working across a wide range of cancer-related research topic areas through the Small Business Innovation Research and Small Business Technology Transfer (SBIR & STTR) Omnibus Solicitation, an investigator-initiated grant funding opportunity. The next deadline to submit applications is August 5, 2013.

The original SBIR and STTR Omnibus Solicitations, PA-13-088 (SBIR) and PA-13-089 (STTR) are now expired.

  • Applicants will receive an error during submission if these expired funding opportunity announcements (FOAs) are used.
  • Please download and use the re-issued Omnibus Solicitation FOAs (PA-13-234, SBIR and PA-13-235, STTR) for all applications to the remaining due dates. This includes resubmissions (‘-A1s’).

The re-issued 2013 Omnibus Solicitation expands eligibility and impacts the application process, so please read the solicitations carefully. With this re-issue, the NIH SBIR/STTR programs implement the following provisions of the SBIR/STTR Reauthorization Act:

  • Small business concerns that are majority-owned by multiple venture capital operating companies (VCOCs), hedge funds and/or private equity firms are now eligible to apply to the NIH SBIR program and compete for up to 25% of NIH’s SBIR set-aside.
  • All applicants are required to register at the SBA Company Registry prior to application submission and attach proof of registration.

For further details, please see NIH Guide Notice NOT-OD-13-071 or check the NIH implementation plan website.

To view the official re-issued 2013 SBIR & STTR Omnibus Solicitations, please visit:

SBIR Program
PA-13-234, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Receipt Dates: August 5, 2013; December 5, 2013

STTR Program
PA-13-235, Re-issue PHS 2013-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42])
Receipt Dates: August 5, 2013; December 5, 2013

How to Apply
For resources and tips for applying, please click here.

NCI encourages U.S. small businesses to submit investigator-initiated SBIR & STTR grant applications for any mission-aligned innovative technologies. To review descriptions of research topics of particular interest, please click here. For more information about this opportunity, please click here.

Please visit http://sbir.cancer.gov/ to learn more about the NCI SBIR & STTR Programs.

 

The SBIR & STTR Programs are NCI’s engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.

Sign up to receive updates about
SBIR & STTR funding opportunities at
sbir.cancer.gov

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: